PharmaCyte Biotech (PMCB) Research & Development (2014 - 2026)
PharmaCyte Biotech (PMCB) posted Research & Development of $60,000 for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 36.9% from $95,157 a year earlier and down 3.1% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Research & Development (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Research & Development at PharmaCyte Biotech was $356,144, down 18.6% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $391,301, down 10.7% from FY2025.
- Annual Research & Development shows a five-year compound annual growth rate of -15.6% (FY2021 to FY2026).
- In prior fiscal years, PharmaCyte Biotech's Research & Development was $438,416 in FY2025 (+7.6%), $407,431 in FY2024 (-13.0%), $468,536 in FY2023 (-32.2%) and $690,937 in FY2022 (-24.6%).
- The fiscal Q1 2027 figure stands as the lowest quarterly Research & Development since fiscal Q3 2023.
- On a year-over-year basis, Research & Development has declined in each of the last three quarters, with an average decline of 2.3% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was fiscal Q3 2024, with growth of 179.2%; the weakest was fiscal Q3 2023, with a decline of 71.3%.
- According to Business Quant data, Research & Development for the three prior fiscal quarters was $61,946 (Q4 2026), $93,113 (Q3 2026) and $141,085 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | 60,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 60,000.00 |
| Apr 30, 2026 | 61,946.00 |
| Jan 31, 2026 | 93,113.00 |
| Oct 31, 2025 | 141,085.00 |
| Jul 31, 2025 | 95,157.00 |
| Apr 30, 2025 | 126,734.00 |
| Jan 31, 2025 | 118,196.00 |
| Oct 31, 2024 | 97,470.00 |
| Jul 31, 2024 | 96,016.00 |
| Apr 30, 2024 | 94,183.00 |
| Jan 31, 2024 | 126,732.00 |
| Oct 31, 2023 | 82,033.00 |
| Jul 31, 2023 | 104,483.00 |
| Apr 30, 2023 | 85,874.00 |
| Jan 31, 2023 | 45,393.00 |
| Oct 31, 2022 | 177,996.00 |
| Jul 31, 2022 | 159,273.00 |
| Apr 30, 2022 | 254,065.00 |
| Jan 31, 2022 | 158,039.00 |
| Oct 31, 2021 | 135,220.00 |
API Access
PharmaCyte Biotech Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();